VENICE Trial at 2 Years with Dr. Leo Seibold | The Long View Ep. 2

What do the two-year VENICE trial data tell us about eye pressure and the need for glaucoma drops? In Episode 2 of The Long View, Dr. Leonard “Leo” Seibold of the University of Colorado walks through the 24-month interim results from VENICE. The trial compares two minimally invasive glaucoma surgery (MIGS) procedures, canaloplasty with STREAMLINE and trabecular bypass with iStent inject W, each performed alongside cataract surgery. Watch the full episode for Dr. Seibold’s take on intraocular pressure, how many patients were still off glaucoma drops at two years, and what he’s looking for in the full study results. Subscribe to IDSocial for more episodes of The Long View. #TheLongView #Glaucoma #MIGS #Ophthalmology